Cartesian Therapeutics Inc (RNAC)

Income Before Tax

-$161.08M

TTM · Period ending: · USD

RNAC logo

RNAC Income Before Tax

Latest reported-$161.08M
RNAC TTM Pre-Tax Income (-$25.17M → -$161.08M)
High-resolution chart · PNG

RNAC income before tax history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Cartesian Therapeutics Inc Income Before Tax — Trailing twelve months (TTM) (USD)
Period endingIncome Before Tax (USD)
-161,084,000
-160,967,000
-139,495,000
-47,692,000
-35,973,000
-38,023,000
-77,137,000
-263,829,000
-248,648,000
-273,871,000
-238,710,000
-36,447,000
-35,659,000
-15,671,000
34,770,000
41,542,000
47,690,000
43,654,000
-9,721,000
-37,544,000
-45,207,000
-73,853,000
-68,876,000
-68,318,000
-70,583,000
-62,896,000
-55,350,000
-55,113,000
-59,120,000
-61,522,000
-65,336,000
-70,229,000
-68,904,000
-66,075,000
-65,321,000
-59,860,000
-52,912,000
-43,868,000
-36,210,000
-28,976,000
-26,973,000
-26,917,000
-25,174,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.